1. Home
  2. APRE vs ECDA Comparison

APRE vs ECDA Comparison

Compare APRE & ECDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APRE
  • ECDA
  • Stock Information
  • Founded
  • APRE 2006
  • ECDA 2013
  • Country
  • APRE United States
  • ECDA United States
  • Employees
  • APRE N/A
  • ECDA N/A
  • Industry
  • APRE Biotechnology: Biological Products (No Diagnostic Substances)
  • ECDA Auto Manufacturing
  • Sector
  • APRE Health Care
  • ECDA Consumer Discretionary
  • Exchange
  • APRE Nasdaq
  • ECDA Nasdaq
  • Market Cap
  • APRE 8.3M
  • ECDA 7.7M
  • IPO Year
  • APRE 2019
  • ECDA N/A
  • Fundamental
  • Price
  • APRE $1.51
  • ECDA $3.06
  • Analyst Decision
  • APRE Strong Buy
  • ECDA
  • Analyst Count
  • APRE 1
  • ECDA 0
  • Target Price
  • APRE $20.00
  • ECDA N/A
  • AVG Volume (30 Days)
  • APRE 50.3K
  • ECDA 338.4K
  • Earning Date
  • APRE 11-06-2025
  • ECDA 11-24-2025
  • Dividend Yield
  • APRE N/A
  • ECDA N/A
  • EPS Growth
  • APRE N/A
  • ECDA N/A
  • EPS
  • APRE N/A
  • ECDA N/A
  • Revenue
  • APRE $841,012.00
  • ECDA $25,158,832.00
  • Revenue This Year
  • APRE N/A
  • ECDA $21.59
  • Revenue Next Year
  • APRE N/A
  • ECDA N/A
  • P/E Ratio
  • APRE N/A
  • ECDA N/A
  • Revenue Growth
  • APRE N/A
  • ECDA 8.48
  • 52 Week Low
  • APRE $1.37
  • ECDA $2.60
  • 52 Week High
  • APRE $5.01
  • ECDA $46.20
  • Technical
  • Relative Strength Index (RSI)
  • APRE 51.04
  • ECDA 51.86
  • Support Level
  • APRE $1.40
  • ECDA $2.80
  • Resistance Level
  • APRE $1.53
  • ECDA $4.98
  • Average True Range (ATR)
  • APRE 0.08
  • ECDA 0.41
  • MACD
  • APRE 0.01
  • ECDA -0.23
  • Stochastic Oscillator
  • APRE 67.77
  • ECDA 9.18

About APRE Aprea Therapeutics Inc. Common stock

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company. The group is focused on precision oncology through synthetic lethality. Its pipeline products include ATRN-119, a clinical-stage small molecule ATR inhibitor in development for solid tumor indications. APR-1051, an oral, small-molecule WEE1 inhibitor, recently entered the clinic.

About ECDA ECD Automotive Design Inc.

ECD Automotive Design Inc is a custom-car builder in the Restomod sector with a focus on British classic motor vehicles of various models of both two-door and four-door styles. The company has established a facility geared towards producing the majority customized Land Rovers with the highest quality of parts and the highest quality labor force building each vehicle. ECD restores Land Rovers Defenders, Land Rover Series IIA, the Range Rover Classic and the Jaguar E-Type. It upgrade any engine, including Chevrolet V8's, Land Rover V8's, Cummins diesel engines and new electric drivetrains, performing all the necessary body work, drivetrain selection and installation, every stitch in the interior, paint work, up to placement of the last nut and bolt.

Share on Social Networks: